We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$263M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$35.7M |
| 2 |
Merck
MRK
|
+$30.3M |
| 3 |
Microsoft
MSFT
|
+$22.4M |
| 4 |
Yum China
YUMC
|
+$17.6M |
| 5 |
Occidental Petroleum
OXY
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$36.5M |
| 2 |
Intel
INTC
|
+$32.4M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
| 4 |
NVR
NVR
|
+$16.3M |
| 5 |
Deere & Co
DE
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
QuinStreet
QNST
$870M
| $1.23M | 0.02% |
147,099
+101,049
| +219% | +$858K |
|
|
EXTN
577
DELISTED
Exterran Corporation
EXTN
| $1.23M | 0.02% |
39,043
+24,203
| +163% | +$749K |
|
|
NPKI
578
NPK International
NPKI
$1.21B
| $1.22M | 0.02% |
141,372
+101,572
| +255% | +$919K |
|
|
TPIC
579
DELISTED
TPI Composites
TPIC
| $1.21M | 0.02% |
59,156
+43,076
| +268% | +$902K |
|
580
Biglari Holdings Class B
BH
$1.2B
| $1.21M | 0.02% |
4,364
+1,182
| +37% | +$284K |
|
581
CNX Resources
CNX
$4.85B
| $1.2M | 0.02% |
+81,800
| New | +$1.13M |
|
582
Portland General Electric
POR
$6.02B
| $1.18M | 0.02% |
+25,950
| New | +$1.23M |
|
583
First Bancorp
FBNC
$2.6B
| $1.17M | 0.02% |
33,125
+12,678
| +62% | +$460K |
|
|
HIFR
584
DELISTED
InfraREIT, Inc.
HIFR
| $1.17M | 0.02% |
62,844
+19,501
| +45% | +$415K |
|
|
PFC
585
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.16M | 0.02% |
44,640
+8,220
| +23% | +$221K |
|
586
HNI Corp
HNI
$3B
| $1.15M | 0.02% |
+29,843
| New | +$1.09M |
|
587
First Bancorp
FBP
$4.4B
| $1.14M | 0.02% |
223,133
-264,474
| -54% | -$1.32M |
|
588
WaFd
WAFD
$2.72B
| $1.14M | 0.02% |
33,196
-65,323
| -66% | -$2.24M |
|
589
SouthState Bank Corp
SSB
$10.3B
| $1.14M | 0.02% |
13,039
-1,800
| -12% | -$162K |
|
|
HT
590
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $1.14M | 0.02% |
65,227
-33,908
| -34% | -$607K |
|
591
QCR Holdings
QCRH
$1.65B
| $1.12M | 0.02% |
26,158
+8,367
| +47% | +$382K |
|
|
SP
592
DELISTED
SP Plus Corporation
SP
| $1.12M | 0.02% |
30,145
+2,340
| +8% | +$90.9K |
|
593
SLB Ltd
SLB
$77.8B
| $1.12M | 0.02% |
16,580
-7,670
| -32% | -$497K |
|
594
Zumiez
ZUMZ
$320M
| $1.12M | 0.02% |
53,581
+7,700
| +17% | +$147K |
|
595
Zimmer Biomet
ZBH
$17.7B
| $1.11M | 0.02% |
9,466
-3,018
| -24% | -$341K |
|
596
A.O. Smith
AOS
$8.38B
| $1.1M | 0.02% |
17,960
-18,330
| -51% | -$1.11M |
|
597
Orion Group Holdings
ORN
$514M
| $1.1M | 0.02% |
140,386
+24,500
| +21% | +$182K |
|
|
BDSI
598
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $1.09M | 0.02% |
370,216
+150,347
| +68% | +$416K |
|
|
MDSO
599
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.07M | 0.02% |
+16,950
| New | +$1.21M |
|
|
NXRT
600
NexPoint Residential Trust
NXRT
$665M
| $1.07M | 0.02% |
38,271
+18,259
| +91% | +$483K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2017 Portfolio in Review
As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.
- Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
- Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
- Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
- Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.